- Pulwama attack: Reason, not emotions must drive our response to Pakistan
- Arpit Palace owner arrested at IGI Airport for hotel fire that killed 17
- IL&FS-led liquidity woes, Aadhaar ban roil NBFCs, micro-lending dips by 15%
- How easy credit from shadow banks has begun to haunt Indian realty sector
- Modi to visit Jharkhand, lay foundation stone for hospitals, water schemes
- Nissan weighs outside director as board chairman as Carlos Ghosn's era ends
|BSE: 500087||Sector: Health care|
|NSE: CIPLA||ISIN Code: INE059A01026|
|BSE 00:00 | 15 Feb||540.40||
|NSE 00:00 | 15 Feb||540.55||
|Mkt Cap.(Rs cr)||43,540|
|Mkt Cap.(Rs cr)||43540.03|
Cipla Ltd. (CIPLA) - Latest News & Headlines
8.39 am | 6 Feb 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
12.40 pm | 28 Jan 2019 | Business Standard
Reliance Capital, Reliance Home Finance and Reliance Infrastructure from Anil Ambani-led Reliance Group were among 70 stocks from the Nifty 500 index ...
2.50 pm | 30 Dec 2018 | Press Trust of India
As per the latest Enforcement Report by the USFDA, the reason for the recall of the bottles is 'failed dissolution specifications'
11.50 am | 10 Dec 2018 | Business Standard
Coal India, ONGC, NTPC, Sun Pharma, Tata Motors, Tata Motors DVR and Vedanta were among seven stocks from the S&P BSE Sensex hit 52-week lows today.
10.30 am | 3 Dec 2018 | Business Standard
Nifty Pharma index emerged as the top sectoral loser on NSE in the morning deals on Monday, weighed down by the shares of Sun Pharmaceutical Industrie...
12.59 am | 3 Dec 2018 | Business Standard
Drug makers are consolidating manufacturing facilities and rationalising their product portfolio in the US as they battle price erosion and weak profi...
8.28 am | 14 Nov 2018 | Business Standard
Acquisition to help the company build a specialty pipeline in the US
12.00 am | 7 Nov 2018 | Press Trust of India
At NSE, shares of the company dropped 5.87% to close at Rs 529.95
10.59 am | 6 Nov 2018 | Business Standard
The stock was down 5% at Rs 534, trading at its lowest level since June 6, 2018 on the BSE.
12.45 am | 6 Nov 2018 | Business Standard
Company cautious on prospects, given supply disruptions & commodity inflation, among others
9.44 pm | 5 Nov 2018 | Business Standard
Tender business, which accounts for around 20% of consolidated sales, came under pressure because of intense competition and aggressive pricing
2.53 pm | 5 Nov 2018 | Business Standard
The stock has dipped 8% to Rs 558 on the BSE after the pharmaceutical company posted 11% decline in its consolidated net profit at Rs 3.77 billion for...
10.31 am | 29 Oct 2018 | Business Standard
Cipla's Metoprolol ER Tablets 50mg, 100mg, 200mg is AB-rated beta1-selective adrenoceptor blocking agent
10.25 am | 15 Oct 2018 | Business Standard
Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.
10.16 pm | 9 Oct 2018 | Business Standard
In India, the company is by far the leader in the respiratory drugs segment, having a turnover of over Rs 18.93 billion
9.48 pm | 30 Sep 2018 | Business Standard
'We are looking to provide end-to-end solutions in the area of disease management for Patients'
10.37 am | 14 Sep 2018 | Business Standard
Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat open-an...
9.00 am | 12 Sep 2018 | Business Standard
Sun Pharma said the US health regulator USFDA was conducting an inspection of its Mohali facility in Punjab.
3.21 pm | 6 Sep 2018 | Business Standard
Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.
10.20 am | 23 Aug 2018 | Business Standard
Nifty Pharma index hit a 52-week high of 10,142, rising 2%, in early morning deal, surpassing its previous high of 10,063 recorded on November 3, 2017...